Table of Contents
1 Table of Contents 2
1.1 List of Tables 7
1.2 List of Figures 9
2
Introduction 11
2.1 What Is This Report About? 11
3 Definitions of the
Markets Covered in the Report 12
3.1 Ophthalmic Devices 12
3.2
Cataract Surgery 12
3.2.1 Phacoemulsification Equipment 12
3.2.2 Intra
Ocular Lens 12
3.3 Vision Care 12
3.3.1 Ophthalmoscopes 12
3.3.2
Contact lenses 12
3.3.3 Lens care 12
3.3.4 Ophthalmic lens 13
3.3.5 Rigid Gas Permeable Contact Lenses 13
3.4 Refractive Surgery 13
4 Healthcare Sector Review 14
4.1 Healthcare Expenditure 14
4.2
Healthcare Infrastructure 16
4.2.1 Healthcare Personnel Data 17
4.2.2
Healthcare Facilities Data 18
4.3 Healthcare Policy 19
5 Regulation
System 21
5.1 Medical Equipment Approval Process 21
5.1.1
Classification 22
5.1.2 Conformity Assessment Process 31
5.2
Notification Fee 35
6 Pricing and Reimbursement 36
6.1 Reimbursement
Policies 36
7 Distribution Structure 37
8 Ophthalmic Devices In
Belgium 38
8.1 Ophthalmic Devices Cross Country Comparison (2000-2012)
38
8.2 Ophthalmic Devices, Belgium, Overall Revenues ($ mn), 2000-2012
39
8.3 Ophthalmic Devices, Belgium, Category Volume (Units), 2000-2012
43
8.4 Ophthalmic Devices, Belgium Company share (2006-2007) 44
9
Cataract Surgery In Belgium 45
9.1 Cataract Surgery Overall Revenue
(2000-2012) 45
9.2 Cataract Surgery Overall Volume (2000-2012) 47
9.3
Cataract Surgery Average Price (2000-2012) 48
9.4 Cataract Surgery
Distribution Share (2006-2007) 48
9.5 Cataract Surgery, Belgium, Company
Share (2006-2007) 49
10 Refractive Surgery In Belgium 50
10.1
Refractive Surgery Overall Revenue (2000-2012) 50
10.2 Refractive Surgery
Overall Volume (2000-2012) 52
10.3 Refractive Surgery Average Price
(2000-2012) 54
10.4 Refractive Surgery Distribution Share (2006-2007)
54
10.5 Refractive Surgery, Belgium, Company Share (2006-2007) 55
11
Vision Care In Belgium 56
11.1 Vision Care Overall Revenue (2000-2012)
56
11.2 Vision Care Overall Volume (2000-2012) 59
11.3 Vision Care
Average Price (2000-2012) 61
11.4 Vision Care Distribution Share
(2006-2007) 62
11.5 Vision Care, Belgium, Company Share (2006-2007) 63
12 Alcon, Inc. Company Profile 64
12.1 Company Overview 64
12.2 Value
Chain Analysis 64
12.2.1 Manufacturing 65
12.2.2 Product Development
65
12.2.3 Sales and Marketing 66
12.2.4 Alcon, Inc. Pipeline Products
by Equipment Type 67
12.2.5 Alcon, Inc. Pipeline Products by Development
Stage 67
12.2.6 Alcon, Inc. Pipeline Products by Therapy Area 67
12.2.7 Alcon, Inc. Pipeline Products by Clinical Trials 68
12.2.8 Alcon,
Inc. Pipeline Products by News Summary 68
13 Bausch & Lomb Incorporated
Company Profile 69
13.1 Company Overview 69
13.2 Value Chain Analysis
69
13.2.1 Manufacturing 70
13.2.2 Product Development 70
13.2.3
Sales and Marketing 71
13.3 Bausch & Lomb Incorporated Pipeline Products
71
13.3.1 Bausch & Lomb Incorporated Pipeline Products by Equipment Type
71
13.3.2 Bausch & Lomb Incorporated Pipeline Products by Development
Stage 72
13.3.3 Bausch & Lomb Incorporated Pipeline Products by Therapy
Area 72
13.3.4 Bausch & Lomb Incorporated Pipeline Products by Clinical
Trials 72
13.3.5 Bausch & Lomb Incorporated Pipeline Products by News
Summary 72
14 Johnson & Johnson Vision Care, Inc. Company Profile 73
14.1 Company Overview 73
15 Essilor International Company Profile 74
15.1 Company Overview 74
15.2 Value Chain Analysis 74
15.2.1
Manufacturing 74
15.2.2 Product Development 75
15.2.3 Sales and
Marketing 75
16 Advanced Medical Optics, Inc. Company Profile 76
16.1
Company Overview 76
16.2 Value Chain Analysis 76
16.2.1 Manufacturing
77
16.2.2 Product Development 77
16.2.3 Sales and Marketing 78
16.2.4 Advanced Medical Optics, Inc. Pipeline Products by Equipment Type
78
16.2.5 Advanced Medical Optics, Inc. Pipeline Products by Development
Stage 78
16.2.6 Advanced Medical Optics, Inc. Pipeline Products by Therapy
Area 78
16.2.7 Advanced Medical Optics, Inc. Pipeline Products by Clinical
Trials 79
17 CIBA Vision Corporation Company Profile 80
17.1 Company
Overview 80
17.1.1 CIBA Vision Corporation Pipeline Products by Equipment
Type 80
17.1.2 CIBA Vision Corporation Pipeline Products by Development
Stage 80
17.1.3 CIBA Vision Corporation Pipeline Products by Therapy Area
80
17.1.4 CIBA Vision Corporation Pipeline Products by Clinical Trials
80
18 APPENDIX 81
18.1 Global Markets Direct Research Methodology
81
18.2 Coverage 82
18.3 Secondary Research 82
18.4 Primary
Research 83
18.5 Models 83
18.6 Forecasts 84
18.7 Expert Panels
84
18.8 Currency Conversion 85
18.9 Contact Us 86
18.10 Disclaimer
86
1.1 List of Tables
Table 1: Hospitals and Hospital Beds in
Belgium, 2005 16
Table 2: Number of Doctors by Specialty in Belgium,
2003-2007 17
Table 3: Number of Hospital Wards by Specialty in Belgium,
2003-2007 18
Table 4: Medical Equipment Notification Fee in Belgium, 2007
35
Table 5: Ophthalmic Devices Cross Country Comparison (2000-2012) 38
Table 6: Ophthalmic Devices, Belgium, Overall Revenues ($ mn), 2000-2012
39
Table 7: Ophthalmic Devices, Belgium, Portfolio Analysis, 2000-2012
40
Table 8: Ophthalmic Devices, Belgium, Overall Revenues ($ mn),
Historic, 2000-2007 41
Table 9: Ophthalmic Devices, Belgium, Overall
Revenues ($ mn), Forecast, 2007-2012 42
Table 10: Ophthalmic Devices,
Belgium, Category Volume (Units), 2000-2012 43
Table 11: Ophthalmic
Devices, Belgium, Category Volume (Units), Historic, 2000-2007 43
Table
12: Ophthalmic Devices, Belgium, Category Volume (Units), Forecast, 2007-2012
43
Table 13: Ophthalmic Devices, Belgium Company share by Revenue ($ mn),
2006-2007 44
Table 14: Cataract Surgery, Belgium, Revenue ($ mn) by
Segment, Historic, 2000-2007 45
Table 15: Cataract Surgery, Belgium,
Revenue ($ mn) by Segment, Forecast, 2007-2012 46
Table 16: Cataract
Surgery, Belgium, Overall Volume (Units), Historic, 2000-2007 47
Table 17:
Cataract Surgery, Belgium, Overall Volume (Units), Forecast, 2007-2012 47
Table 18: Cataract Surgery, Belgium, Average Price ($), Historic, 2000-2007
48
Table 19: Cataract Surgery, Belgium, Average Price ($), Forecast,
2007-2012 48
Table 20: Cataract Surgery, Belgium, Distribution Share by
Revenue ($mn), 2006-2007 48
Table 21: Cataract Surgery, Belgium, Company
Share by Revenue ($ mn), 2006-2007 49
Table 22: Refractive Surgery,
Belgium, Revenue ($ mn), Historic, 2000-2007 50
Table 23: Refractive
Surgery, Belgium, Revenue ($ mn), Forecast, 2007-2012 51
Table 24:
Refractive Surgery, Belgium, Overall Volume (Units), Historic, 2000-2007
52
Table 25: Refractive Surgery, Belgium, Overall Volume (Units),
Forecast, 2007-2012 53
Table 26: Refractive Surgery, Belgium, Average
Price ($), Historic, 2000-2007 54
Table 27: Refractive Surgery, Belgium,
Average Price ($), Forecast, 2007-2012 54
Table 28: Refractive Surgery,
Belgium, Distribution Share by Revenue ($mn), 2006-2007 54
Table 29:
Refractive Surgery, Belgium, Company Share by Revenue ($ mn), 2006-2007 55
Table 30: Vision Care, Belgium, Revenue ($ mn) by Segment, Historic, 2000-2007
57
Table 31: Vision Care, Belgium, Revenue ($ mn) by Segment, Forecast,
2007-2012 58
Table 32: Vision Care, Belgium, Overall Volume (Units),
Historic, 2000-2007 59
Table 33: Vision Care, Belgium, Overall Volume
(Units), Forecast, 2007-2012 60
Table 34: Vision Care, Belgium, Average
Price ($), Historic, 2000-2007 61
Table 35: Vision Care, Belgium, Average
Price ($), Forecast, 2007-2012 61
Table 36: Vision Care, Belgium,
Distribution Share by Revenue ($mn), 2006-2007 62
Table 37: Vision Care,
Belgium, Company Share by Revenue ($ mn), 2006-2007 63
Table 38: Alcon,
Inc. Pipeline Products by Equipment Type 67
Table 39: Alcon, Inc. Pipeline
Products By Development Stage 67
Table 40: Alcon, Inc. Pipeline Products
By Therapy Area 67
Table 41: Alcon, Inc. Pipeline Products By Clinical
Trials 68
Table 42: Alcon, Inc. Pipeline Products By News Summaries 68
Table 43: Bausch & Lomb Incorporated Pipeline Products by Equipment Type
71
Table 44: Bausch & Lomb Incorporated Pipeline Products By Development
Stage 72
Table 45: Bausch & Lomb Incorporated Pipeline Products By Therapy
Area 72
Table 46: Bausch & Lomb Incorporated Pipeline Products By Clinical
Trials 72
Table 47: Bausch & Lomb Incorporated Pipeline Products By News
Summaries 72
Table 48: Advanced Medical Optics, Inc. Pipeline Products by
Equipment Type 78
Table 49: Advanced Medical Optics, Inc. Pipeline
Products By Development Stage 78
Table 50: Advanced Medical Optics, Inc.
Pipeline Products By Therapy Area 78
Table 51: Advanced Medical Optics,
Inc. Pipeline Products By Clinical Trials 79
Table 52: CIBA Vision
Corporation Pipeline Products by Equipment Type 80
Table 53: CIBA Vision
Corporation Pipeline Products by Development Stage 80
Table 54: CIBA
Vision Corporation Pipeline Products By Therapy Area 80
Table 55: CIBA
Vision Corporation Pipeline Products By Clinical Trials 80
Table 56:
Currency Conversion from USD to Local Currency at 2007 Constant Rate 85
1.2 List of Figures
Figure 1: Total Healthcare Expenditure in
Belgium, 2000 -- 2006 15
Figure 2: Structure of Healthcare System in
Belgium, 2007 20
Figure 3: Flowchart for Classification of Non-invasive
Devices in Belgium, 2007 23
Figure 4: Flowchart for Classification of
Invasive Devices in Belgium, 2007 24
Figure 5: Flowchart for
Classification of Invasive Devices in Belgium, 2007 25
Figure 6: Flowchart
for Classification of Invasive Devices in Belgium, 2007 26
Figure 7:
Flowchart for Classification of Invasive Devices in Belgium, 2007 27
Figure 8: Flowchart for Classification of Active Devices in Belgium, 2007
28
Figure 9: Flowchart for Classification of Active Devices in Belgium,
2007 29
Figure 10: Flowchart for Classification of Devices except
Non-invasive, Invasive and Active Devices in Belgium, 2007 30
Figure 11:
Conformity Assessment of Class-I Medical Devices in Belgium, 2007 31
Figure 12: Conformity Assessment of Class-IIa Medical Devices in Belgium, 2007
32
Figure 13: Conformity Assessment of Class-IIb Medical Devices in
Belgium, 2007 33
Figure 14: Conformity Assessment of Class-III Medical
Devices in Belgium, 2007 34
Figure 15: Ophthalmic Devices Cross Country
Comparison (2000-2012) 38
Figure 16: Ophthalmic Devices, Belgium, Overall
Revenues ($ mn), 2000-2012 39
Figure 17: Ophthalmic Devices, Belgium,
Portfolio Analysis, 2000-2012 40
Figure 18: Ophthalmic Devices, Belgium,
Overall Revenues ($ mn), Historic, 2000-2007 41
Figure 19: Ophthalmic
Devices, Belgium, Overall Revenues ($ mn), Forecast, 2007-2012 42
Figure
20: Ophthalmic Devices, Belgium Company share (%), 2007 44
Figure 21:
Cataract Surgery, Belgium, Revenue ($ mn) by Segment, Historic, 2000-2007
45
Figure 22: Cataract Surgery, Belgium, Revenue ($ mn) by Segment,
Forecast, 2007-2012 46
Figure 23: Cataract Surgery, Belgium, Company Share
(%), 2007 49
Figure 24: Refractive Surgery, Belgium, Revenue ($ mn),
Historic, 2000-2007 50
Figure 25: Refractive Surgery, Belgium, Revenue ($
mn), Forecast, 2007-2012 51
Figure 26: Refractive Surgery, Belgium,
Overall Volume (Units), Historic, 2000-2007 52
Figure 27: Refractive
Surgery, Belgium, Overall Volume (Units), Forecast, 2007-2012 53
Figure
28: Refractive Surgery, Belgium, Company Share (%), 2007 55
Figure 29:
Vision Care, Belgium, Revenue ($ mn) by Segment, Historic, 2000-2007 56
Figure 30: Vision Care, Belgium, Revenue ($ mn) by Segment, Forecast,
2007-2012 58
Figure 31: Vision Care, Belgium, Overall Volume (Units),
Historic, 2000-2007 59
Figure 32: Vision Care, Belgium, Overall Volume
(Units), Forecast, 2007-2012 60
Figure 33: Vision Care, Belgium, Company
Share (%), 2007 63
Figure 34: Alcon, Inc. Value Chain Analysis 64
Figure 35: Bausch & Lomb Incorporated Value Chain Analysis 69
Figure 36:
Essilor International Value Chain Analysis 74
Figure 37: Advanced Medical
Optics, Inc. Value Chain Analysis 76
Figure 38: Global Markets Direct
Methodology 81
|
Related Report
|
View Cart
